Tevogen Bio Holdings Stock Today
| TVGN Stock | 1.31 0.06 4.38% |
Performance10 of 100
| Odds Of DistressLess than 20
|
Tevogen Bio is selling at 1.31 as of the 30th of November 2024; that is 4.38 percent decrease since the beginning of the trading day. The stock's open price was 1.37. Tevogen Bio has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. Tevogen Bio symbol was changed from LGST on 15th of February 2024. Equity ratings for Tevogen Bio Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of February 2024 | Category Healthcare | Classification Health Care |
Tevogen Bio is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 164.61 M outstanding shares of which 774.71 K shares are at this time shorted by private and institutional investors with about 0.07 trading days to cover. More on Tevogen Bio Holdings
Moving together with Tevogen Stock
Moving against Tevogen Stock
Tevogen Stock Highlights
| Older Symbol | LGST | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CEO CoFounder | MPH MD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tevogen Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Tevogen Bio's financial leverage. It provides some insight into what part of Tevogen Bio's total assets is financed by creditors. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tevogen Bio Holdings (TVGN) is traded on NASDAQ Exchange in USA. It is located in 15 Independence Boulevard, Warren, NJ, United States, 07059 and employs 12 people. Tevogen Bio Holdings was previously known as Semper Paratus Acquisition and was traded on NASDAQ Exchange under the symbol LGST. Tevogen Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 164.61 M. Tevogen Bio Holdings conducts business under Biotechnology sector and is part of Health Care industry. The entity has 164.61 M outstanding shares of which 774.71 K shares are at this time shorted by private and institutional investors with about 0.07 trading days to cover.
Tevogen Bio generates negative cash flow from operations
Check Tevogen Bio Probability Of Bankruptcy
Ownership AllocationTevogen Bio Holdings shows a total of 164.61 Million outstanding shares. Tevogen Bio Holdings has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 96.61 % of Tevogen Bio outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that roughly one million nine hundred fifty-eight thousand nine hundred seven invesors are currently shorting Tevogen Bio expressing very little confidence in its future performance.
Check Tevogen Ownership Details
Tevogen Bio Historical Income Statement
Tevogen Stock Against Markets
Tevogen Bio Corporate Management
| Susan MBA | Independent Officer | Profile | |
| Mittul Mehta | Chief Tevogenai | Profile | |
| Sadiq Khan | Chief Officer | Profile | |
| Jeffrey MPH | Member Officer | Profile | |
| Tapan Shah | Head Development | Profile | |
| Kirti CPA | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.83) |
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.